Solid Biosciences Competitors, Revenue and Alternatives
Estimated Revenue & Financials
- Solid Biosciences's estimated annual revenue is currently $12.4M per year.
- Solid Biosciences received $133.7M in venture funding in February 2018.
- Solid Biosciences's estimated revenue per employee is $120,388
- Solid Biosciences's total funding is $217.5M.
- Solid Biosciences has 103 Employees.
- Solid Biosciences grew their employee count by -34% last year.
- Solid Biosciences currently has 1 job openings.
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|Cell Signaling ...||$89.4M||577||N/A||N/A|
What Is Solid Biosciences?
Solid Biosciences (Solid) is a Cambridge, MA based biotech company singularly focused on developing treatments and cures for Duchenne muscular dystrophy (DMD). Solid combines sharp commercial focus with world-class science to advance promising therapies and is positioned to catalyze therapeutic development across all aspects of the disease. Condition-focused, our mandate is comprehensive; improving daily life for patients and attacking the roots of DMD.keywords:Biotechnology,Healthcare,Pharmaceuticals
Number of Employees
Employee Growth %
|Lineka Gousby||Office Manager|
|Debra Segal||Vice President, Regulatory Affairs||Email Available|
|Kara Clarke||Senior Manager, Talent Acquisition|
|Angel Cortes||Sr Manager, Quality Control|
|Patrick Redman||Senior Project Manager, R&D|
|Kristy Brown||Associate Director R&D|
|Christine Kitsos||Director, Head of Analytical Development|
|Alvaro Amorrortu||Chief Operating Officer|
|Susan Redican||Senior Director, Clinical Operations|
|Pamela Lawrence||Executive Assistant To Cso And Cto|
Solid Biosciences News
Following the near 100% rally in shares of Solid Biosciences Inc (NASDAQ: SLDB) in August, one Citigroup analyst said the stock price is ...
Shares of the gene therapy biotech specialist Solid Biosciences slid Thursday morning as an analyst at Citi Research argued that it was time to ...
Investors are constantly examining different company financial indicators to assess trading opportunities. Solid Biosciences Inc.
Solid Biosciences Funding
|2015-11-04||$42.5M||B||erceptive Advisors, LLC||Article|
|2017-03-31||$50.0M||C||RA Capital Management||Article|